Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, November 20, 2024.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Crossroads (-60) - XERS is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid XERS?
MarketClub looks at technical strength and momentum to determine if the timing is right for XERS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for XERS
The long-term trend has been UP since Jul 16th, 2024 at 2.510000
The intermediate-term trend has been DOWN since Nov 15th, 2024 at 2.962669
The short-term trend has been DOWN since Nov 8th, 2024 at 3.100000
Smart Scan Analysis for XERS
Based on our trend formula, XERS is rated as a -60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 2.860 | 3.010 | 2.860 | 3.005 | +0.105 |
| Prev. Close | Volume | Bid | Ask | Time |
| 3.010 | 688870 | 2024-11-19 15:59:29 |
| Year High | 27.9826 | Year High Date | 2018-09-12 |
| Year Low | 15.75 | Year Low Date | 2018-06-21 |
| 52wk High | 3.64 | 52wk High Date | 2024-11-08 |
| 52wk Low | 1.69 | 52wk Low Date | 2024-04-26 |
| Average Volume | 1,966,511 | Shares Outstanding | 149,081 |
| Market Cap | 275M | Assets | 321,104,000M |
| Liabilities | 349,427,000M | P/E Ratio | -4.52630000 |
| Volatility | 56.41 |